Skip to main content
logo
Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
0.7974
+0.0104 (1.32%)
Aug 7, 2026, 4:00 PM EDT - Market closed

Actinium Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
35.090.09-0.081.031.14
Revenue Growth
----92.14%-9.96%-
Gross Profit
35.090.09-0.081.031.14
Operating Income
9.56-36.25-42.12-51.92-34.1-24.96
Net Income
11.31-33.89-38.24-48.82-33.02-24.77
Earnings Per Share
0.36-1.09-1.27-1.83-1.37-1.20
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
36.474872.976.68108.9177.83
Total Debt
1.341.691.572.112.580.31
Net Cash (Debt)
35.1346.371.3374.56106.3377.52
Net Cash Growth
-40.09%-35.09%-4.34%-29.87%37.16%23.39%
Net Cash Per Share
1.121.482.372.804.403.77

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-22.66-24.58-33.07-47.348.64-20.87
Capital Expenditures
-0.58-0.1-0.01-0.15-0.37-0.13
Free Cash Flow
-23.25-24.68-33.08-47.498.28-21
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%-100.00%100.00%100.00%
Operating Margin
27.23%-40274.40%--64098.80%-3311.07%-2182.17%
Pretax Margin
79.51%-37652.22%--60269.14%-3205.53%-2165.56%
Profit Margin
32.23%-37652.20%--60269.10%-3205.53%-2165.56%
FCF Margin
-66.25%-27426.70%--58627.20%803.69%-1835.58%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
----33.03-
PS Ratio
0.71471.41-1733.11265.47116.33